Medium materiality6/10
NeuroOne Medical price target lowered to 5 from 13 at Maxim
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Maxim cuts NMTC target to 5; current price is 1.81. Despite the downgrade, price remains well below the target, implying upside potential.
- Target lowered to 5; price 1.81
- Upside potential remains
Key facts
- 01
Target: $5
- 02
Posted price: $1.81
- 03
Analyst firm: Maxim Group
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.